 | Aileron Therapeutics, Inc. | |||
| NCM : ALRN || Location: United States | ||||
$4.74-0.26 (-5.2%) |
0.09 M | 4.6 - 5.03 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.035 M |
| March 15, 2024 | 0.033 M |
| Feb. 29, 2024 | 0.038 M |
| Feb. 15, 2024 | 0.031 M |
| Jan. 31, 2024 | 0.040 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2023 | -0.88 | -1.05 | -19.70% |
| 12/31/2022 | -1.37 | -1.02 | 25.37% |
| 09/30/2022 | -1.68 | -1.40 | 16.82% |
| 06/30/2022 | -1.84 | -1.80 | 1.96% |
| 03/31/2022 | -1.53 | -1.80 | -17.60% |
ALRN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 16.973M | Shares Float | 13.923M |
| Short Float | 0.035M | Market Cap | 84.86M |
| Institution ownership | 18.19% | Insider ownership | 0.202% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.42 | Forward EPS | -0.78 |